Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-58094
Wong , W W; Boutros, P C; Wasylishen, A R; Guckert, K D; O'Brien, E M; Griffiths, R; Martirosyan, A R; Bros, C; Jurisica, I; Langler, R F; Penn, L Z (2010). Characterization of the apoptotic response of human leukemia cells to organosulfur compounds. BMC Cancer, 10:351.
|Published Version (English)|
Background: Novel therapeutic agents that selectively induce tumor cell death are urgently needed in the clinical
management of cancers. Such agents would constitute effective adjuvant approaches to traditional chemotherapy
regimens. Organosulfur compounds (OSCs), such as diallyl disulfide, have demonstrated anti-proliferative effects on
cancer cells. We have previously shown that synthesized relatives of dysoxysulfone, a natural OSC derived from the
Fijian medicinal plant, Dysoxylum richi, possess tumor-specific antiproliferative effects and are thus promising lead
Methods: Because our structure-activity analyses showed that regions flanking the disulfide bond mediated
specificity, we synthesized 18 novel OSCs by structural modification of the most promising dysoxysulfone derivatives.
These compounds were tested for anti-proliferative and apoptotic activity in both normal and leukemic cells.
Results: Six OSCs exhibited tumor-specific killing, having no effect on normal bone marrow, and are thus candidates
for future toxicity studies. We then employed mRNA expression profiling to characterize the mechanisms by which
different OSCs induce apoptosis. Using Gene Ontology analysis we show that each OSC altered a unique set of
pathways, and that these differences could be partially rationalized from a transcription factor binding site analysis. For
example, five compounds altered genes with a large enrichment of p53 binding sites in their promoter regions (p <
Conclusions: Taken together, these data establish OSCs derivatized from dysoxysulfone as a novel group of
compounds for development as anti-cancer agents.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Institute of Experimental Immunology|
|DDC:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||11 Mar 2012 15:11|
|Last Modified:||18 Mar 2014 07:50|
|Citations:||Web of Science®. Times Cited: 3|
Scopus®. Citation Count: 3
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page